PSTPIP2: A Potential Cancer Drug Target (G9050)
PSTPIP2: A Potential Cancer Drug Target
Post-Transcriptional Modification-Informed Polymorphism (PSTPIP2) is a non-coding RNA molecule that plays a crucial role in regulating gene expression in various organisms, including humans. PSTPIP2 is a protein that is composed of 219 amino acids and has been shown to have various functions in different cellular processes, including cell adhesion, migration, and invasion.
PSTPIP2 as a drug target
PSTPIP2 has been identified as a potential drug target in the field of cancer. Several studies have shown that PSTPIP2 can be downregulated in various types of cancer, including breast, lung, and ovarian cancer. This downregulation of PSTPIP2 has been associated with the development of cancer stem cells, which are cancer-promoting cells that can resist chemotherapy and radiation treatment.
One of the potential mechanisms by which PSTPIP2 contributes to cancer development is by regulating the activity of cell signaling pathways that promote the growth and survival of cancer cells. For example, PSTPIP2 has been shown to play a role in the regulation of the TGF-β pathway, which is a well-known signaling pathway that promotes the growth and survival of cancer cells.
Another potential mechanism by which PSTPIP2 contributes to cancer development is by regulating the activity of cell signaling pathways that promote the angiogenesis of cancer. Angiogenesis is the process by which new blood vessels are formed in the body, and it is a critical process for the growth and survival of cancer cells.
PSTPIP2 has been shown to play a role in the regulation of angiogenesis by the production of pro-angiogenic factors, such as VEGF. VEGF is a potent angiogenic factor that promotes the formation of new blood vessels, and it has been shown to contribute to the development of various types of cancer, including cancer.
In conclusion, PSTPIP2 is a non-coding RNA molecule that has been identified as a potential drug target in the field of cancer. Its functions in regulating cell signaling pathways and the regulation of angiogenesis have been well-studied, and its potential as a drug target is under investigation. Further research is needed to determine the exact mechanisms by which PSTPIP2 contributes to cancer development and the potential of PSTPIP2 as a drug.
Protein Name: Proline-serine-threonine Phosphatase Interacting Protein 2
Functions: Binds to F-actin. May be involved in regulation of the actin cytoskeleton (By similarity)
More Common Targets
PTAFR | PTAR1 | PTBP1 | PTBP2 | PTBP3 | PTCD1 | PTCD2 | PTCD3 | PTCH1 | PTCH2 | PTCHD1 | PTCHD1-AS | PTCHD3 | PTCHD3P1 | PTCHD3P2 | PTCHD4 | PTCRA | PTCSC2 | PTCSC3 | PTDSS1 | PTDSS2 | PTEN | PTENP1 | PTENP1-AS | PTER | PTF1A | PTGDR | PTGDR2 | PTGDS | PTGER1 | PTGER2 | PTGER3 | PTGER4 | PTGER4P2-CDK2AP2P2 | PTGES | PTGES2 | PTGES2-AS1 | PTGES3 | PTGES3L | PTGES3L-AARSD1 | PTGES3P1 | PTGES3P2 | PTGES3P3 | PTGFR | PTGFRN | PTGIR | PTGIS | PTGR1 | PTGR2 | PTGR3 | PTGS1 | PTGS2 | PTH | PTH1R | PTH2 | PTH2R | PTK2 | PTK2B | PTK6 | PTK7 | PTMA | PTMAP1 | PTMAP5 | PTMAP7 | PTMS | PTN | PTOV1 | PTOV1-AS1 | PTOV1-AS2 | PTP4A1 | PTP4A1P2 | PTP4A2 | PTP4A3 | PTPA | PTPDC1 | PTPMT1 | PTPN1 | PTPN11 | PTPN11P5 | PTPN12 | PTPN13 | PTPN14 | PTPN18 | PTPN2 | PTPN20 | PTPN20A | PTPN20CP | PTPN21 | PTPN22 | PTPN23 | PTPN3 | PTPN4 | PTPN5 | PTPN6 | PTPN7 | PTPN9 | PTPRA | PTPRB | PTPRC | PTPRCAP